- Home
- CGEN vs GMGI Comparison
CGEN vs GMGI Comparison
Compare CGEN & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGEN | GMGI |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.1M | 115.8M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGEN | GMGI |
|---|---|---|
| Price | $1.48 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 405.6K | 241.1K |
| Earning Date | 11-10-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,903,000.00 | ★ $179,142,103.00 |
| Revenue This Year | N/A | $25.59 |
| Revenue Next Year | $231.15 | $14.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.24 |
| 52 Week Low | $1.13 | $0.70 |
| 52 Week High | $2.66 | $2.60 |
Technical Indicators
Market Signals| Indicator | CGEN | GMGI |
|---|---|---|
| Relative Strength Index (RSI) | 40.30 | 46.61 |
| Support Level | $1.47 | $0.80 |
| Resistance Level | $1.55 | $0.87 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 16.98 | 54.67 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.